Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
3H Health Investment is a dedicated healthcare private equity fund focusing on China. We believe that the combination of our proactive and creative investment approach, deep understanding of the China market, extensive industry network, and excellent fund management experience provides us with an edge in identifying and creating value in investment opportunities.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2020 | Shenqi Medical | Series C | 14.5M |
4/2020 | MicroPort CardioFlow | Private Equity Round | 130M |
4/2021 | EdiGene | Series B | 61.6M |
11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
9/2020 | Edge Medical Robotics | Series B | 14.7M |
10/2020 | Hemu (China) Biological Engineering | Series B | 14M |
5/2021 | Reliable Med | Series A | - |
6/2022 | Yuanyin Bio | Series A | 0 |
10/2020 | EdiGene | Series B | 0 |
12/2020 | WT Microtech Medical | Series D | 0 |
11/2021 | Edge Medical Robotics | Series C | 0 |
9/2021 | Vision X | Series B | - |
4/2023 | Alebund Pharmaceuticals | Series C | 0 |
7/2020 | Citrine Medicine | Series A | 0 |
9/2021 | Alebund Pharmaceuticals | Series B | 0 |
6/2022 | Yuanyin Bio | Series A | 0 |
11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
11/2021 | Edge Medical Robotics | Series C | 0 |
9/2021 | Vision X | Series B | - |
9/2021 | Alebund Pharmaceuticals | Series B | 0 |
5/2021 | Reliable Med | Series A | - |
4/2021 | EdiGene | Series B | 0 |
12/2020 | WT Microtech Medical | Series D | 0 |
10/2020 | Hemu (China) Biological Engineering | Series B | 0 |
10/2020 | EdiGene | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|